Auto-generated from public data. Not the firm's stated position.
Trill Impact appears to focus on early to growth-stage investments across biotech, cleantech, and adjacent sectors, with a disclosed check size floor of €3.0M. Recent portfolio companies suggest interest in climate technology, space-based data infrastructure, and specialized pharmaceutical development, indicating a thesis spanning sustainability and health innovation.
Generated 18 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-detected from Trill Impact's website.
Senior Investment Director with 15+ years in private equity and investment banking, previously Principal at FSN Capital.
Investment Manager focusing on Buyout, previously at EQT Stockholm investing in North European mid-cap companies.
Partner with 15+ years in life science R&D and venture capital, previously Investment Director at Industrifonden.
Partner with 18+ years in private equity, formerly Head of Asia for KKR Global Impact Fund.
Investment Manager focusing on Buyout, previously Vice President at Triton Partners in Frankfurt.
Impact Partner with 18+ years in impact and ESG investing across public and private markets.
Investment Manager focusing on Buyout, previously Associate at McKinsey & Company.
Head of Microfinance, previously Senior Investment Manager at Swedfund.
Founder and Managing Partner with 25+ years in private equity, formerly Deputy CEO at EQT Partners.
Partner with 15+ years in institutional capital raising and investor relations for private investing.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.